Radioimmunotherapy Market By Radioisotopes (Actnium-225, Astatine 211, Bismuth 212, Lead 212, Bismut

Published Date: | Report Code : HC2059132

X

The Radioimmunotherapy Market report highlights market opportunities and competitive scenarios for radioimmunotherapy on a regional and global basis. Market size estimation and forecasts have been provided based on a unique research design customized to the dynamics of the radioimmunotherapy market. The radioimmunotherapy market has been segmented by radioisotopes: actnium-225, astatine 211, bismuth 212, lead 212, bismuth 213 and thorium 227, phosphorus 32, phosphorus 33, cupper 67, yttrium 80 , iodine 131 and lutetium 177 by emitters type: alpha emitters, beta emitters and others by end users: hospitals, clinics and others by cancer types: lymphoma, colorectal cancer, prostate cancer, breast cancer, cervical cancer, lung cancer and others region: north america, europe, asia pacific, middle east and rest of the world. Historic back-drop for radioimmunotherapy market has been analyzed according to organic and inorganic developments to provide precise market size estimations. Also, key factors impacting the growth of the radioimmunotherapy market have been identified with potential gravity. Major regions covered in the study include North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World.

Market Segmentation:

By Radioisotopes :

  • Actnium-225
  • Astatine 211
  • Bismuth 212
  • Lead 212
  • Bismuth 213 and Thorium 227
  • Phosphorus 32
  • Phosphorus 33
  • Cupper 67
  • Yttrium 80
  • Iodine 131 and Lutetium 177

By Emitters Type:

  • Alpha Emitters

  • Beta Emitters

  • Others 

End Users:

  • Hospitals

  • Clinics

  • Others

By Cancer Types:

  • Lymphoma

  • Colorectal Cancer

  • Prostate Cancer

  • Breast Cancer

  • Cervical Cancer

  • Lung Cancer and Others

By End User:  

  • Manufacturing
  • Aerospace & Defense
  • Healthcare
  • Automotive
  • Transportation
  • Government

By Region:

  • North America
    • North America, by Country
      • US
      • Canada
      • Mexico
    • North America, by Radioisotopes
    • North America, by End-User
    • North America, by Emitters Type
    • North America, by Cancer Types
  • Western Europe
    • Western Europe, by Country
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Western Europe
    • Western Europe, by Radioisotopes
    • Western Europe, by End-User
    • Western Europe, by Emitters Type
    • Western Europe, by Cancer Types
  • Asia Pacific
    • Asia Pacific, by Country
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Indonesia
      • Rest of Asia Pacific
    • Asia Pacific, by Radioisotopes
    • Asia Pacific, by End-User
    • Asia Pacific, by by Emitters Type
    • Asia Pacific, by Cancer Types
  • Eastern Europe
    • Eastern Europe, by Country
      • Russia
      • Turkey
      • Rest of Eastern Europe
    • Eastern Europe, by Radioisotopes
    • Eastern Europe, by End-User
    • Eastern Europe, by Emitters Type
    • Eastern Europe, by Cancer Types
  • Middle East
    • Middle East, by Country
      • UAE
      • Saudi Arabia
      • Qatar
      • Iran
      • Rest of Middle East
    • Middle East, by Radioisotopes
    • Middle East, by End-User
    • Middle East, by Emitters Type
    • Middle East, by Cancer Types
  • Rest of the World
    • Rest of the World, by Country
      • South America
      • Africa
    • Rest of the World, by Radioisotopes
    • Rest of the World, by End-User
    • Rest of the World, by Emitters Type
    • Rest of the World, by Cancer Types

Major Companies: Actinium Pharmaceuticals, GlaxoSmithKline, Bayer AG, MabVax Therapeutics Holdings, Inc., Immunomedics, Inc., Panacea Pharmaceuticals, Inc. Nordic Nanovector, Inc., Spectrum Pharmaceuticals, Inc.

Years Covered in the Study:

Historic Year: 2016-2017

Base Year:2018

Estimated Year: 2019

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for radioimmunotherapy market on regional and global basis.
  • To identify major segments in radioimmunotherapy market and evaluate theirmarket shares and demand.
  • To provide a competitive scenario for the radioimmunotherapy market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of radioimmunotherapy market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the radioimmunotherapy market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the radioimmunotherapy market.

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis
  • For more information, contact:[email protected]

License Offering

Single User (PDF)

3850

Multi User (PDF)

5150

Enterprise User (PDF)

7650

Get Regional Report USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy